Borrow it
Coverart for item
The Resource Pharmaceutical science to improve the human condition : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010, (electronic resource)

Pharmaceutical science to improve the human condition : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010, (electronic resource)

Contributor
Summary
"This Annals volume includes scholarly summaries of scientific achievement by winners and finalist candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards. The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country's significant advances in pharmaceutical research. Until the establishment of the Prix Galien, this discipline was unrecognized. Mehl brought together an eminent jury of clinicians, toxicologists, pharmacologists, and pharmacists to select and honor the most important drugs introduced to the public market and the most significant research teams in the pharmaceutical field. Since then, the Prix Galien has been introduced across Europe and Canada, and is now the most prestigious award of its kind in 11 countries. In addition, an International Prix Galien award is given each year, selected from previous winners. Contributions in the present volume--from top researchers in the biopharmaceutical industry, and the esteemed Bro Bono Humanitarian award winners President William Clinton and Dr. Philippe Douste-Blasy, with a special introduction by Secretary-General of the United Nations Ban Ki-moon--best embody humanitarianism and therapeutic promise in global healthcare problems. Winners and select finalists of the 2010 Prix Galien prizes represent biotechnical advances poised to combat a wide range of diseases and viruses."--Publisher's description
Language
eng
Work
Publication
Extent
1 online resource (100 pages)
Note
Title from resource title screen (Wiley Online Library, viewed March 28, 2011)
Contents
  • Foreword / Ban Ki-Moon
  • Prix Galien Pro Bono Humanitarian Award Winner: Philippe Douste-Blazy / Philippe Douste-Blazy
  • Prix Galien Pro Bono Humanitarian Award Winner: William J. Clinton / William J. Clinton
  • Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel / Nancy Krunic ... [et al.]
  • Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine / Michelle G. Goveia ... [et al.]
  • Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria / Gilbert Lefèvre, Anne Claire Marrast and Heiner Grueninger
  • Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives / Newman Yeilding ... [et al.]
  • Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting / Richard Hargreaves ... [et al.]
  • Linezolid, the first oxazolidinone antibacterial agent / Karen L. Leach ... [et al.]
  • The development of romiplostim for patients with immune thrombocytopenia/ Graham Molineux
  • The discovery and development of rivaroxaban / Frank Misselwitz, Scott D. Berkowitz and Elisabeth Perzborn
  • A review of the history, properties, and use of the immunomodulatory compound / Jerome B. Zeldis ... [et al.]
  • Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium / Bach-Yen T. Nguyen ... [et al.]
  • Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine / Emmanuel Canet, Guy Lerebours and Jean-Paul Vilaine
Instance
Label
Pharmaceutical science to improve the human condition : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010
Title
Pharmaceutical science to improve the human condition
Title remainder
winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010
Title variation
  • Winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010
  • Prix Galien 2010
Contributor
Subject
Language
eng
Summary
"This Annals volume includes scholarly summaries of scientific achievement by winners and finalist candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards. The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country's significant advances in pharmaceutical research. Until the establishment of the Prix Galien, this discipline was unrecognized. Mehl brought together an eminent jury of clinicians, toxicologists, pharmacologists, and pharmacists to select and honor the most important drugs introduced to the public market and the most significant research teams in the pharmaceutical field. Since then, the Prix Galien has been introduced across Europe and Canada, and is now the most prestigious award of its kind in 11 countries. In addition, an International Prix Galien award is given each year, selected from previous winners. Contributions in the present volume--from top researchers in the biopharmaceutical industry, and the esteemed Bro Bono Humanitarian award winners President William Clinton and Dr. Philippe Douste-Blasy, with a special introduction by Secretary-General of the United Nations Ban Ki-moon--best embody humanitarianism and therapeutic promise in global healthcare problems. Winners and select finalists of the 2010 Prix Galien prizes represent biotechnical advances poised to combat a wide range of diseases and viruses."--Publisher's description
Member of
Cataloging source
MMU
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
QV 20.5
http://library.link/vocab/relatedWorkOrContributorDate
1946-
http://library.link/vocab/relatedWorkOrContributorName
  • Ki-moon, Ban
  • Clinton, Bill
  • Douste-Blazy, Philippe
  • New York Academy of Sciences
Series statement
Annals of the New York Academy of Sciences,
Series volume
v. 1222
http://library.link/vocab/subjectName
  • Awards and Prizes
  • Pharmacology
  • Drug Industry
  • Research
Label
Pharmaceutical science to improve the human condition : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010, (electronic resource)
Instantiates
Publication
Note
Title from resource title screen (Wiley Online Library, viewed March 28, 2011)
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Foreword / Ban Ki-Moon -- Prix Galien Pro Bono Humanitarian Award Winner: Philippe Douste-Blazy / Philippe Douste-Blazy -- Prix Galien Pro Bono Humanitarian Award Winner: William J. Clinton / William J. Clinton -- Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel / Nancy Krunic ... [et al.] -- Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine / Michelle G. Goveia ... [et al.] -- Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria / Gilbert Lefèvre, Anne Claire Marrast and Heiner Grueninger -- Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives / Newman Yeilding ... [et al.] -- Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting / Richard Hargreaves ... [et al.] -- Linezolid, the first oxazolidinone antibacterial agent / Karen L. Leach ... [et al.] -- The development of romiplostim for patients with immune thrombocytopenia/ Graham Molineux -- The discovery and development of rivaroxaban / Frank Misselwitz, Scott D. Berkowitz and Elisabeth Perzborn -- A review of the history, properties, and use of the immunomodulatory compound / Jerome B. Zeldis ... [et al.] -- Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium / Bach-Yen T. Nguyen ... [et al.] -- Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine / Emmanuel Canet, Guy Lerebours and Jean-Paul Vilaine
Control code
709619550
Extent
1 online resource (100 pages)
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations (some color).
Specific material designation
remote
System control number
(OCoLC)709619550
Label
Pharmaceutical science to improve the human condition : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010, (electronic resource)
Publication
Note
Title from resource title screen (Wiley Online Library, viewed March 28, 2011)
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Foreword / Ban Ki-Moon -- Prix Galien Pro Bono Humanitarian Award Winner: Philippe Douste-Blazy / Philippe Douste-Blazy -- Prix Galien Pro Bono Humanitarian Award Winner: William J. Clinton / William J. Clinton -- Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel / Nancy Krunic ... [et al.] -- Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine / Michelle G. Goveia ... [et al.] -- Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria / Gilbert Lefèvre, Anne Claire Marrast and Heiner Grueninger -- Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives / Newman Yeilding ... [et al.] -- Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting / Richard Hargreaves ... [et al.] -- Linezolid, the first oxazolidinone antibacterial agent / Karen L. Leach ... [et al.] -- The development of romiplostim for patients with immune thrombocytopenia/ Graham Molineux -- The discovery and development of rivaroxaban / Frank Misselwitz, Scott D. Berkowitz and Elisabeth Perzborn -- A review of the history, properties, and use of the immunomodulatory compound / Jerome B. Zeldis ... [et al.] -- Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium / Bach-Yen T. Nguyen ... [et al.] -- Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine / Emmanuel Canet, Guy Lerebours and Jean-Paul Vilaine
Control code
709619550
Extent
1 online resource (100 pages)
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations (some color).
Specific material designation
remote
System control number
(OCoLC)709619550

Subject

Genre

Member of

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377

Library Links

Structured data from the Bibframe namespace is licensed under the Creative Commons Attribution 4.0 International License by University of Missouri Libraries. Additional terms may apply to data associated with third party namespaces.
Processing Feedback ...